NO843591L - Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne - Google Patents

Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne

Info

Publication number
NO843591L
NO843591L NO843591A NO843591A NO843591L NO 843591 L NO843591 L NO 843591L NO 843591 A NO843591 A NO 843591A NO 843591 A NO843591 A NO 843591A NO 843591 L NO843591 L NO 843591L
Authority
NO
Norway
Prior art keywords
pivka
executing
contents
procedure
determining
Prior art date
Application number
NO843591A
Other languages
English (en)
Other versions
NO163920C (no
NO163920B (no
Inventor
Ichiro Matsuda
Kunihiko Motohara
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO843591L publication Critical patent/NO843591L/no
Publication of NO163920B publication Critical patent/NO163920B/no
Publication of NO163920C publication Critical patent/NO163920C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO843591A 1983-09-13 1984-09-11 Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever. NO163920C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58167458A JPS6060557A (ja) 1983-09-13 1983-09-13 Ｐｉｖｋａ−２の測定方法および試薬

Publications (3)

Publication Number Publication Date
NO843591L true NO843591L (no) 1985-03-14
NO163920B NO163920B (no) 1990-04-30
NO163920C NO163920C (no) 1990-08-08

Family

ID=15850047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843591A NO163920C (no) 1983-09-13 1984-09-11 Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.

Country Status (8)

Country Link
US (1) US4780410A (no)
EP (1) EP0142634B1 (no)
JP (1) JPS6060557A (no)
KR (1) KR880001338B1 (no)
AT (1) ATE48037T1 (no)
CA (1) CA1234045A (no)
DE (1) DE3480494D1 (no)
NO (1) NO163920C (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769320A (en) * 1982-07-27 1988-09-06 New England Medical Center Hospitals, Inc. Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations
DK0500921T3 (da) * 1990-09-11 1999-11-29 Univ California Na-K-ATPase-inhiberende natriuretiske substanser
JPH0720127A (ja) * 1993-05-07 1995-01-24 Eisai Co Ltd 各種ｐｉｖｋａの測定方法および測定試薬
DE19941447C2 (de) * 1999-08-14 2002-06-27 November Ag Molekulare Medizin Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus
ATE265048T1 (de) * 1999-08-14 2004-05-15 November Ag Molekulare Medizin Verfahren zur indirekten bestimmung des blutgerinnungsstatus
US6893831B1 (en) * 1999-12-14 2005-05-17 Sanko Junyaku Co., Ltd. Immunoassay of PIVKA-II
FI119203B (fi) * 2005-03-21 2008-08-29 Juha Horsti Menetelmä protrombiiniajan määrittämiseksi
US9120862B2 (en) * 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
CN107102135A (zh) * 2011-05-20 2017-08-29 阿波特日本有限公司 用于减少非特异性结合的免疫检验方法和试剂
US10641768B2 (en) * 2011-07-08 2020-05-05 Abbott Japan Co. Ltd. Methods and kits for decreasing interferences from leukocytes in specific binding assays
JP6032470B2 (ja) 2012-08-09 2016-11-30 富士レビオ株式会社 Ｐｉｖｋａ−ｉｉ測定方法、測定試薬及び測定キット
JP2013152247A (ja) * 2013-04-12 2013-08-08 Abbott Japan Co Ltd 非特異的相互作用抑制剤及びその診断測定系への応用
EP3361252A4 (en) * 2015-10-07 2019-04-10 Fujirebio Inc. PIVKA II TEST METHOD AND METHOD FOR PRODUCING A REAGENT OR KIT FOR PIVKA II IMMUNOASSAY
CN106468711A (zh) * 2016-09-07 2017-03-01 北京热景生物技术股份有限公司 Dcp快速分离检测试剂盒
CN114729935A (zh) 2019-11-29 2022-07-08 积水医疗株式会社 使用免疫反应的分析物的测量方法和测量试剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS57136165A (en) * 1981-02-18 1982-08-23 Mochida Pharmaceut Co Ltd Immunological measuring reagent
JPS57201853A (en) * 1981-06-08 1982-12-10 Toyobo Co Ltd Measuring method for human chorionic gonadotropin

Also Published As

Publication number Publication date
JPS6060557A (ja) 1985-04-08
JPH0543357B2 (no) 1993-07-01
KR880001338B1 (ko) 1988-07-25
DE3480494D1 (en) 1989-12-21
CA1234045A (en) 1988-03-15
EP0142634B1 (en) 1989-11-15
EP0142634A1 (en) 1985-05-29
KR850002385A (ko) 1985-05-13
US4780410A (en) 1988-10-25
ATE48037T1 (de) 1989-12-15
NO163920C (no) 1990-08-08
NO163920B (no) 1990-04-30

Similar Documents

Publication Publication Date Title
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
AU3615384A (en) Method of detecting immiune complexes in serium
DK242781A (da) Assaymetode og reagens dertil
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
EP0143209A3 (en) Method for the immunological determination of proteins in body fluids using monovalent antibody fragments
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
NO870770L (no) FremgangsmŸte for fremstilling av monoklonale antistoffer.
ES550768A0 (es) Procedimiento para la determinacion especifica de alfa-ami- lasa
KR890008313A (ko) 안티 pci모노클론 항체
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
DE3874741D1 (de) Immunassay-verfahren.
NO172549C (no) Monoklonalt humanurokinase-antistoff, immunoabsorberende middel for rensing av humanurokinase samt anvendelse av antistoffet for detektering av humanurokinase
GR3030212T3 (en) Platelet activating factor antagonists.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
DE3650635D1 (de) Monoklonale Antikörper
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
EP0248147A3 (en) Method of determining the presence of cancer cells
SE8101404L (sv) Reagens och sett for bestemning av aldolas av human-muskeltyp
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
YU164090A (sh) Postopek za dokazovanje analitov
ES8802545A1 (es) Un metodo para determinar prolil 4-hidroxilasa humana por inmunoensayo enzimatico o radioinmunoensayo
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
BR9105983A (pt) Anticorpos monoclonais que diferenciam entre proteinas de sequencias nativa e modificada
NO881998L (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker og middel til gjennomfoering av fremgangsmaaten.
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante

Legal Events

Date Code Title Description
MK1K Patent expired